One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease

PURPOSE: The SANSIKA study evaluated the efficacy/safety of 0.1% (1 mg/mL) cyclosporine A cationic emulsion (CsA CE) for treating dry eye disease (DED) with severe keratitis. The double-masked phase demonstrated that CsA CE was effective in reducing corneal damage and ocular surface inflammation, an...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Eur J Ophthalmol
Hoofdauteurs: Baudouin, Christophe, de la Maza, Maite Sainz, Amrane, Mourad, Garrigue, Jean-Sébastien, Ismail, Dahlia, Figueiredo, Francisco C., Leonardi, Andrea
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SAGE Publications 2017
Onderwerpen:
Original Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380090/
https://ncbi.nlm.nih.gov/pubmed/28708219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5301/ejo.5001002
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items